MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 150 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,916,000 | -35.8% | 469,494 | -0.2% | 0.00% | -50.0% |
Q3 2016 | $2,986,000 | +17.4% | 470,238 | -0.3% | 0.00% | +33.3% |
Q2 2016 | $2,543,000 | -24.3% | 471,710 | +17.5% | 0.00% | -25.0% |
Q1 2016 | $3,361,000 | +12.3% | 401,507 | +6.0% | 0.00% | 0.0% |
Q4 2015 | $2,992,000 | -5.4% | 378,686 | +1.9% | 0.00% | 0.0% |
Q3 2015 | $3,163,000 | -31.9% | 371,632 | -1.1% | 0.00% | -33.3% |
Q2 2015 | $4,646,000 | +42.8% | 375,750 | +37.2% | 0.01% | +50.0% |
Q1 2015 | $3,253,000 | +6.9% | 273,816 | +1.6% | 0.00% | 0.0% |
Q4 2014 | $3,044,000 | +27.6% | 269,375 | -0.9% | 0.00% | +33.3% |
Q3 2014 | $2,386,000 | +20.6% | 271,772 | +0.1% | 0.00% | 0.0% |
Q2 2014 | $1,979,000 | +46.4% | 271,406 | +1.2% | 0.00% | +50.0% |
Q1 2014 | $1,352,000 | -5.1% | 268,251 | +0.4% | 0.00% | 0.0% |
Q4 2013 | $1,425,000 | +38.2% | 267,224 | -1.8% | 0.00% | 0.0% |
Q3 2013 | $1,031,000 | -35.2% | 271,998 | +15.1% | 0.00% | -33.3% |
Q2 2013 | $1,592,000 | – | 236,235 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 514,853 | $2,595,000 | 2.23% |
GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $494,000 | 0.48% |
Catalyst Capital Advisors LLC | 380,896 | $1,920,000 | 0.44% |
Knoll Capital Management, LLC | 160,585 | $809,000 | 0.42% |
Tekla Capital Management LLC | 757,050 | $3,816,000 | 0.38% |
FULLER & THALER ASSET MANAGEMENT, INC. | 524,800 | $2,645,000 | 0.13% |
Integre Asset Management, LLC | 103,493 | $522,000 | 0.12% |
CAMBRIDGE TRUST CO | 220,003 | $1,109,000 | 0.10% |
JAMISON EATON & WOOD INC /NJ | 62,782 | $316,000 | 0.09% |
STONERIDGE INVESTMENT PARTNERS LLC | 88,304 | $445,000 | 0.09% |